2011
DOI: 10.1007/s00213-011-2408-z
|View full text |Cite
|
Sign up to set email alerts
|

Modulation of high impulsivity and attentional performance in rats by selective direct and indirect dopaminergic and noradrenergic receptor agonists

Abstract: RationaleImpulsivity is associated with a number of psychiatric disorders, most notably attention deficit/hyperactivity disorder (ADHD). Drugs that augment catecholamine function (e.g. methylphenidate and the selective noradrenaline reuptake inhibitor atomoxetine) have clinical efficacy in ADHD, but their precise mechanism of action is unclear.ObjectiveThe objective of this study is to investigate the relative contribution of dopamine (DA) and noradrenaline (NA) to the therapeutic effects of clinically effecti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

19
122
4

Year Published

2011
2011
2022
2022

Publication Types

Select...
6
3
1

Relationship

2
8

Authors

Journals

citations
Cited by 123 publications
(146 citation statements)
references
References 60 publications
19
122
4
Order By: Relevance
“…The observed effects of atomoxetine are in general agreement with results obtained in Wistar rats during choice behavior in T-maze [8] and in Lister hooded rats in the five-choice serial reaction time task [31]. The results also parallel improvement in visuo-spatial performance in children with ADHD after subchronic atmoxetine [32].…”
Section: Discussionsupporting
confidence: 86%
“…The observed effects of atomoxetine are in general agreement with results obtained in Wistar rats during choice behavior in T-maze [8] and in Lister hooded rats in the five-choice serial reaction time task [31]. The results also parallel improvement in visuo-spatial performance in children with ADHD after subchronic atmoxetine [32].…”
Section: Discussionsupporting
confidence: 86%
“…Amelioration of high impulsivity has been reported for rats chronically self-administering cocaine (Dalley et al 2007) and for experimenter-administered methylphenidate, the D2/3 receptor agonist quinpirole or atomoxetine (Fernando et al 2012). Methylphenidate also caused an upregulation of D2/3 receptors in high-impulsive rats but the opposite neural (and behavioral) effects in controls (Caprioli et al 2014).…”
Section: Addiction Endophenotypes In Experimental Animalsmentioning
confidence: 95%
“…Consistent with these results, the a 2 -adrenergic receptor agonist guanfacine [N-(diaminomethylidene)-2-(2,6-dichlorophenyl) acetamide] suppressed, while the a 2 -adrenergic receptor antagonist yohimbine (methyl (1S,15R,18S,19R,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate) increased, 5-CSRTT premature responses in rats (Sun et al, 2010;Fernando et al, 2012;Pillidge et al, 2014). Thus, while more work remains to clarify the role of specific a 1 -and a 2 -adrenergic subtypes on 5-CSRTT and DRL 72-second behavior, converging pharmacological evidence for NET inhibitors and b 2 -, a 1 -, and a 2 -adrenergic receptor agonists supports the hypothesis that motoric impulsivity is an important aspect for both behavioral paradigms.…”
Section: Rethinking An Empirical Antidepressant Screenmentioning
confidence: 99%